6.08
price down icon13.02%   -0.91
after-market Handel nachbörslich: 6.05 -0.03 -0.49%
loading

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

pulisher
Apr 03, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.

Apr 03, 2025
pulisher
Mar 31, 2025

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - menafn

Mar 31, 2025
pulisher
Mar 29, 2025

HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire

Mar 28, 2025
pulisher
Mar 28, 2025

HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull

Mar 26, 2025
pulisher
Mar 26, 2025

Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Nyxoah Says FDA Issues Approvable Letter for Genio System - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

FDA Clears Path Forward for Nyxoah's Revolutionary Sleep Apnea Treatment - Stock Titan

Mar 26, 2025
pulisher
Mar 16, 2025

Stifel Nicolaus Has Lowered Expectations for Nyxoah (NASDAQ:NYXH) Stock Price - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Stifel cuts Nyxoah stock price target to $15, maintains Buy By Investing.com - Investing.com Canada

Mar 14, 2025
pulisher
Mar 14, 2025

Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

(NYXH) Investment Analysis - Stock Traders Daily

Mar 14, 2025
pulisher
Mar 14, 2025

Stifel cuts Nyxoah stock price target to $15, maintains Buy - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Nyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

H.C. Wainwright maintains Buy on Nyxoah shares, $17 target - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... By GuruFocus - Investing.com Canada

Mar 14, 2025
pulisher
Mar 14, 2025

Nyxoah Reports 2024 Financial Results and U.S. Launch Plans - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Nyxoah Sa’s Earnings Call: Efficacy and Expansion - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Nyxoah Reports Strong Q4 Growth as Sleep Apnea Device Nears FDA Green Light - Stock Titan

Mar 13, 2025
pulisher
Mar 13, 2025

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - The Manila Times

Mar 13, 2025
pulisher
Mar 10, 2025

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

Nyxoah (NYXH) to Release Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz

Mar 05, 2025
pulisher
Mar 03, 2025

(NYXH) Investment Report - news.stocktradersdaily.com

Mar 03, 2025
pulisher
Mar 03, 2025

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Sleep Apnea Innovator Nyxoah Takes Center Stage at Major Healthcare Conference - StockTitan

Mar 03, 2025
pulisher
Mar 02, 2025

Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday - Defense World

Mar 02, 2025
pulisher
Feb 28, 2025

Nyxoah (NYXH) Projected to Post Earnings on Tuesday - MarketBeat

Feb 28, 2025
pulisher
Feb 25, 2025

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) versus Nyxoah (NASDAQ:NYXH) Critical Review - Defense World

Feb 25, 2025
pulisher
Feb 21, 2025

(NYXH) On The My Stocks Page - Stock Traders Daily

Feb 21, 2025
pulisher
Feb 20, 2025

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

Revolutionary Sleep Apnea Treatment Crosses Borders: Inside Genio's Middle East Launch - StockTitan

Feb 19, 2025
pulisher
Feb 18, 2025

Nyxoah Launches Genio Therapy in Middle East with First UAE Implantation - TipRanks

Feb 18, 2025
pulisher
Feb 18, 2025

Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Feb 17, 2025
pulisher
Feb 14, 2025

Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World

Feb 14, 2025
pulisher
Feb 11, 2025

Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert

Feb 11, 2025
pulisher
Feb 10, 2025

(NYXH) Trading Report - Stock Traders Daily

Feb 10, 2025
pulisher
Jan 30, 2025

Trend Tracker for (NYXH) - Stock Traders Daily

Jan 30, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 20, 2025

NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan

Jan 20, 2025
pulisher
Jan 20, 2025

Nyxoah Receives Transparency Notification from BlackRock - TipRanks

Jan 20, 2025
$153.51
price down icon 0.47%
$66.20
price down icon 5.68%
$60.86
price down icon 1.35%
medical_instruments_supplies WST
$203.21
price down icon 7.62%
medical_instruments_supplies COO
$73.77
price down icon 5.63%
medical_instruments_supplies BAX
$28.79
price down icon 8.17%
Kapitalisierung:     |  Volumen (24h):